Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
166 hedge funds and large institutions have $708M invested in Natus Medical Inc in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 65 increasing their positions, 52 reducing their positions, and 25 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 52
3% less funds holding
Funds holding: 171 → 166 (-5)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
32% less capital invested
Capital invested by funds: $1.04B → $708M (-$327M)
63% less call options, than puts
Call options by funds: $1.85M | Put options by funds: $4.99M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$10.5M |
| 2 |
Goldman Sachs
New York
|
+$7.88M |
| 3 |
Renaissance Technologies
New York
|
+$4.96M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$4.42M |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$3.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$17.6M |
| 2 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$14.8M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$7.11M |
| 4 |
BlackRock
New York
|
-$5.94M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$5.71M |
NTUS Hedge Fund Activity: Q1 2020 in Review
166 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q1 2020, worth a combined $708M — down 32% from $1.04B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of NTUS and 22 opened new positions — a net loss of 3 holders — while 52 trimmed existing stakes and 65 added.
The largest buyer was JP Morgan Chase, adding an estimated $10.5M. The largest seller was Janus Henderson Group, cutting an estimated $17.6M.
- 166 institutional investors held Natus Medical Inc (NTUS) as of Q1 2020, down from 171 in Q4 2019.
- Funds reported $708M of Natus Medical Inc stock for Q1 2020, down 32% quarter-over-quarter.
- 22 funds opened new Natus Medical Inc positions in Q1 2020 and 25 closed out, a net change of -3 holders.
- The largest Natus Medical Inc buyer in Q1 2020 was JP Morgan Chase, an estimated $10.5M added.
- The largest Natus Medical Inc seller in Q1 2020 was Janus Henderson Group, an estimated $17.6M sold.
Based on aggregated 13F filings for Q1 2020.